Provenance du réseau au premier degré de Matthias Klaften
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
amcure GmbH
 amcure GmbH BiotechnologyHealth Technology amcure GmbH develops active ingredients for the treatment of angiogenesis-related diseases. It offers a peptide based substance, that targets the tumor specific co-receptors. The company was founded by Matthias Klaften and Alexandra Matzke on December 14, 2011 and is headquartered in Eggenstein-Leopoldshafen, Germany.
3
| Holding Company | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Matthias Klaften via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SPEXIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree |
Statistiques
Internationale
| Allemagne | 4 |
| Suisse | 3 |
Sectorielle
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Founder | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Klaus Dembowsky | 6 |
| Alexandra Matzke | 1 |
| Silvia Giordano | 1 |
- Bourse
- Insiders
- Matthias Klaften
- Connexions Sociétés
